MoonLake Immunotherapeutics (MLTX.BOATS) Q4 2025 Earnings

5NovConfirmed
Q4 2025
-1.1
-1.03
-0.95
-0.88

Details

Expected EPS
-0.878837
Actual EPS
-1.1
Surprise EPS
-0.22
Surprise Percent
+25.17%

Description

MoonLake Immunotherapeutics (MLTX.BOATS) has reported earnings of -1.1 per share for Q4 2025.

0 Comments

Share your thoughts